APMA News - July/August 2018 - 9

REDEFINING
Fracture
HEALING
Recovery
REDEFINING
Fracture
HEALING
Recovery
REDEFINING
Fracture
HEALING
Recovery
REDEFINING
Fracture
HEALING
Recovery
REDEFINING
Fracture
HEALING
Recovery
REDEFINING Fracture HEALING Recovery

PhysioStim™
Bone
Growth
Therapy
devices
PhysioStim™
Bone
Growth
Therapy
devices
PhysioStim™
Bone
Growth
Therapy
devices
PhysioStim™
Bone
Growth
Therapy
devices
PhysioStim™
Bone
Growth
Therapy
devices
provide
360
degrees
PEMF
treatment
PhysioStim™
Boneof
Growth
Therapy
devices
provide
360
degrees
of
PEMF
treatment
provide
360
degrees
of
PEMF
treatment
provide
360
degrees
of
PEMF
treatment
provide
360
degrees
ofsite
PEMF
treatment
around
the
fracture
that
evenly
provide
360
degrees
of
PEMF
treatment
around
the
fracture
site
that
evenly
around
fracture
site
that
evenly
around
the
fracture
site
that
evenly
1,2
around
thethe
fracture
site
that
evenly
1,2
penetrates
across
tissue,
bone
and
fixation
around
the
fracture
site
that
evenly
penetrates
across
tissue,
bone
and
fixation
1,2
1,2
1,2
penetrates
across
tissue,
bone
and
fixation
penetrates
across
tissue,
bone
and
fixation
penetrates
across
tissue,
bone
and
fixation
penetrates across tissue, bone and fixation1,2

1. Data on file. Field mapping analysis conducted by M. Zborowski, Ph.D., Cleveland Clinic. 2. Navarro, M., Michiardi, A., Castano, O., & Planell, J.. (2008). Biomaterials in orthopaedics. Journal of the Royal Society Interface, 5(27), 1137-1158.
1. Data on file. Field mapping analysis conducted by M. Zborowski, Ph.D., Cleveland Clinic. 2. Navarro, M., Michiardi, A., Castano, O., & Planell, J.. (2008). Biomaterials in orthopaedics. Journal of the Royal Society Interface, 5(27), 1137-1158.
Brief Prescribing Information:
Brief
Prescribing
Information:
on
file.
Fieldon
mapping
analysis
conducted
by
M. Zborowski,
Ph.D.,
Cleveland
Clinic.
2. Navarro,
M.,Navarro,
Michiardi,
Castano,
O.,Castano,
& Planell,
J..&(2008).
Biomaterials
in orthopaedics.
Journal
of the
RoyalofSociety
Interface,
5(27),
1137-1158.1137-1158.
1.
Data
Field
mapping
analysis
conducted
by M. Cleveland
Zborowski,
Ph.D.,
Cleveland
Clinic.
M.,A.,
Michiardi,
A.,
Planell,
J.. the
(2008).
Biomaterials
in orthopaedics.
Journal
the Royal
Society1137-1158.
1. Data1.
onData
file.
Field
mapping
analysis
conducted
bytreatment
M. Zborowski,
Ph.D.,
Clinic.
2.
Navarro,
M.,
Michiardi,
A.,excluding
Castano,
O., & Planell,
Biomaterials
inwidth
orthopaedics.
Journal
of
the Royal
Society
Interface,
The
PhysioStim™
devicefile.
is indicated
for the
of an established
nonunion
acquired
secondary
to2.trauma,
vertebrae
and J..
all (2008).
flatO.,bones,
where
of the nonunion
defect
is less
than one-half
the5(27),
width
ofInterface,
the bone5(27),
to be treated. A
1. Data
on file. Field
mapping
analysisforconducted
by M.ofZborowski,
Ph.D.,
Cleveland
Clinic. secondary
2. Navarro,toM.,
Michiardi,
A., Castano,
O.,and
& Planell,
J.. (2008).
Biomaterials
the than
Royalone-half
Society Interface,
The
PhysioStim™
device
is indicated
the treatment
an established
nonunion
acquired
trauma,
excluding
vertebrae
all flat bones,
where
the widthinoforthopaedics.
the nonunionJournal
defect isofless
the width 5(27),
of the 1137-1158.
bone to be treated. A
Brief Prescribing
Information:
Brief
Prescribing
nonunion
isInformation:
considered
to be Information:
established when the fracture site shows no visibly progressive signs of healing. Use of this device is contraindicated where the individual has synovial pseudarthrosis. Demand type pacemaker operation may be adversely afBrief Prescribing
nonunion
isdevice
considered
to be established
when
the
fracture
siteanshows
no visibly
progressive
signs
of healing.
Use
of vertebrae
this
deviceand
isvertebrae
contraindicated
where
thewidth
individual
has
synovial
pseudarthrosis.
Demand
type
pacemaker
operation
maytreated.
be adversely afBrief
Prescribing
Information:
The
PhysioStim™
is
indicated
for
the
treatment
of
an
established
nonunion
acquired
secondary
to
trauma,
excluding
all
flat
bones,
where
the
of
the
nonunion
defect
is
less
than
one-half
the
width
of
the
bone
to the
be
The
PhysioStim™
device
is
indicated
for
the
treatment
of
established
nonunion
acquired
secondary
to
trauma,
excluding
and
all
flat
bones,
where
the
width
of
the
nonunion
defect
is
less
than
one-half
the
width
of
bone
fected
by
exposure
to
pulsed
electromagnetic
fields.
The
safety
and
effectiveness
of
this
device
has
not
been
established
for
individuals
lacking
skeletal
maturity
or
individuals
with
a
nonunion
secondary
to,
or
in
connection
with,
a
pathological
condition.
The PhysioStim™ device is indicated for the treatment of an established nonunion acquired secondary to trauma, excluding vertebrae and all flat bones, where the width of the nonunion defect is less than one-half the width of the bone to be treated.
A to Abe treated. A
fected
by
exposure
to
pulsed
electromagnetic
fields.
The
safety
and
effectiveness
of
this
device
has
not
been
established
for
individuals
lacking
skeletal
maturity
or
individuals
with
a
nonunion
secondary
to,
or
in
connection
with,
a
pathological
condition.
The isPhysioStim™
device
isonindicated
for
the
treatment
oforfracture
an
established
nonunion
acquired
secondary
vertebrae
and
all
flatbeen
bones,
where
the
width
of the
nonunion
defect
isfound
less
than
one-half
theoperation
width
of
the
bone
toafbe treated.
A afnonunion
considered
to
established
when
the
fracture
site
shows
no
visibly
progressive
signs
ofRare
healing.
thisexcluding
device
isthis
contraindicated
where
thereported.
individual
synovial
pseudarthrosis.
type
pacemaker
be adversely
considered
to be the
established
when
the
site
shows
no visibly
signs
oftrauma,
healing.
ofminor
device
is contraindicated
where
the
individual
has
synovial
pseudarthrosis.
type
pacemaker
operation
may
beaf-adversely
The
ofnonunion
thisto
device
forbeuse
patients
who
are
pregnant
nursing
has
not
been
established.
instances
of
reversible
discomfort
have
Fullhas
prescribing
information
canDemand
betype
inDemand
product
labeling
on our
patient
education
nonunion
issafety
considered
beisestablished
when
fracture
site
shows
no
visibly
progressive
signs
ofprogressive
healing.
Use
oftoUse
this
device
isUse
contraindicated
where
the
individual
has synovial
pseudarthrosis.
Demand
pacemaker
operation
may
bemay
adversely
The
safety
of
this
device
for
use
on
patients
who
are
pregnant
or
nursing
has
not
been
established.
Rare
instances
of
reversible
minor
discomfort
have
been
reported.
Full
prescribing
information
can
be
found
in
product
labeling
on
our
patient
education
nonunion
is
considered
to
be
established
when
the
fracture
site
shows
no
visibly
progressive
signs
of
healing.
Use
of
this
device
is
contraindicated
where
the
individual
has
synovial
pseudarthrosis.
Demand
type
pacemaker
operation
may
be adversely
affected
bywww.BoneGrowthTherapy.com
exposure
to exposure
pulsed
electromagnetic
fields.
The
safety
and
of this device
not
beenhas
established
for individuals
maturity
or individuals
a nonunion
or in connection
a pathological
condition.
fected
by
to pulsed
fields.
The
safety
of has
this
device
notfor
been
established
for lacking
individuals
lacking
maturity
individuals
with asecondary
nonunion
secondary
to,with,
or inawith,
connection
with,
a pathological
condition.
website
orelectromagnetic
byThe
calling
Patient
Care
ateffectiveness
1-800-535-4492.
fected by
exposure
to pulsed
electromagnetic
fields.
safety
and
effectiveness
ofand
thiseffectiveness
device
has not
been
established
individuals
lacking
skeletalskeletal
maturity
orskeletal
individuals
with or
a with
nonunion
secondary
to, or into,
connection
pathological
condition.
website
www.BoneGrowthTherapy.com
or
by fields.
calling
Patient
Care
athas
1-800-535-4492.
fected
by
exposure
to
pulsed
electromagnetic
The
safety
and
effectiveness
of
this
device
has
not
been
established
for
individuals
lacking
skeletal
maturity
or
individuals
with
a
nonunion
secondary
to,
or
in
connection
with,
a
pathological
condition.
The
safety
of
this
device
for
use
on
patients
who
are
pregnant
or
nursing
not
been
established.
Rare
instances
of
reversible
minor
discomfort
have
been
reported.
Full
prescribing
information
can
be
found
in
product
labeling
on
our
patient
education
The
safety
of
this
device
for
use
on
patients
who
are
pregnant
or
nursing
has
not
been
established.
Rare
instances
of
reversible
minor
discomfort
have
been
reported.
Full
prescribing
information
can
be
found
in
product
labeling
on
our
patient
education
Caution:
Federal
law
(USA)
restricts
this
device
to
sale
by
or
on
the
order
of
a
physician.
The safety of this device for use on patients who are pregnant or nursing has not been established. Rare instances of reversible minor discomfort have been reported. Full prescribing information can be found in product labeling on our patient education
Caution:
Federal
law
(USA)
restricts
this
device
to
sale
by
or
on
the
order
of
a
physician.
The
safety
of this
device fororuse
who
arecalling
pregnant
or nursing
not been established. Rare instances of reversible minor discomfort have been reported. Full prescribing information can be found in product labeling on our patient education
www.BoneGrowthTherapy.com
orpatients
by calling
Care
at 1-800-535-4492.
website
www.BoneGrowthTherapy.com
orPatient
by
Patient
Care at has
1-800-535-4492.
websitewebsite
www.BoneGrowthTherapy.com
byon
calling
Patient
Care
at
1-800-535-4492.
website
www.BoneGrowthTherapy.com
by
calling
Care
atof1-800-535-4492.
Caution:
Federal
lawrestricts
(USA) restricts
thisrestricts
device
to
sale
bythe
ortoPatient
on
theby
a physician.
Caution:
Federal
law
(USA)
this
sale
on
the
order of a physician.
Caution:
Federal
law
(USA)
this device
to sale or
by
ordevice
on
order
oforder
aorphysician.
Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

BSA-1717 Print © Orthofix Holdings, Inc. 1/2018
BSA-1717 Print © Orthofix Holdings, Inc. 1/2018
BSA-1717
Print
© Orthofix
Holdings,
Inc.
1/2018Inc. 1/2018
Print ©
Orthofix
Holdings,
BSA-1717
Print ©BSA-1717
Orthofix
Holdings,
Inc. 1/2018
BSA-1717 Print © Orthofix Holdings, Inc. 1/2018
BSA-1804.3 © Orthofix Holdings, Inc. 6/2018
BSA-1804.3 © Orthofix Holdings, Inc. 6/2018
BSA-1804.3
© Orthofix
Holdings,
Inc.
6/2018Inc. 6/2018
BSA-1804.3
©
Orthofix
Holdings,
BSA-1804.3
© Orthofix
Holdings,
Inc. 6/2018
BSA-1804.3 © Orthofix Holdings, Inc. 6/2018

BoneGrowthTherapy.com
BoneGrowthTherapy.com
orthofix.com
BoneGrowthTherapy.com
BoneGrowthTherapy.com
orthofix.com
BoneGrowthTherapy.com
BoneGrowthTherapy.com
1.800.535.4492
orthofix.com
orthofix.com
1.800.535.4492
orthofix.com
orthofix.com
1.800.535.4492
1.800.535.4492
1.800.535.4492
1.800.535.4492

http://bonegrowththerapy.com http://bonegrowththerapy.com http://orthofix.com

Table of Contents for the Digital Edition of APMA News - July/August 2018